If you used hair relaxers; you could be entitled to significant compensation.
Get a 100% Free Case Evaluation
Lawsuits claim that these products increase the risk of many uterine, endometrial or ovarian cancers.
0+
Affected0x
Higher risk of cancer0+
Cases PendingAs seen on
Settlements Still Available:
For decades, millions of women—especially Black women—have trusted hair relaxers to achieve their desired look, whether at home or in salons. But what many didn’t know is that these products could be putting their health at serious risk. Heartbreaking lawsuits reveal that women across the nation have developed life-threatening conditions, such as uterine cancer, breast cancer, and painful uterine fibroids, after years of using chemical hair relaxers and straighteners.
These brave women are now speaking out, and the legal system is listening. The cases have been consolidated into a Multidistrict Litigation (MDL) to hold major manufacturers accountable for the toxic chemicals they've put in their products—chemicals that may be causing devastating cancers and illnesses.
If you or a loved one has suffered after using these products, you could be entitled to compensation. Don’t wait—fill out the form today for a free case review and take the first step toward getting the justice and settlement you deserve.
Hair Relaxers and Cancer
Hair relaxers are formulated with chemicals designed to temporarily straighten curly hair by breaking down the protein bonds in the hair. However, some of these chemicals are known to be endocrine disruptors, posing potential health risks.
Endocrine-disrupting chemicals (EDCs) interfere with the body’s endocrine system, which regulates hormone production, storage, and secretion. EDCs in hair relaxers can be absorbed through the scalp, especially through cuts, burns, or sores, leading to increased exposure.
Frequent use of hair relaxers has been linked to a higher risk of estrogen-dependent cancers, such as:
- Endometrial cancer
- Uterine cancer
Research shows that women who use chemical hair straighteners more than four times a year are about 2.5 times more likely to develop uterine cancer.
Black women may be particularly vulnerable to the harmful effects of hair relaxers and the EDCs they contain. According to a National Institutes of Health (NIH) study, nearly 60% of participants who reported using chemical straighteners in the past year identified as Black women.
In response to these health risks, families across the country are pursuing legal action by filing hair relaxer lawsuits against the manufacturers of these hazardous products, seeking justice for the harm caused.
Who Qualifies?
Hair Relaxer Lawsuit Updates 2023-2024
In February 2023, hair relaxer cases were consolidated into a multidistrict litigation (MDL) or class action lawsuit. Since then, each new development in the hair relaxer lawsuit has brought victims harmed by these chemical products one step closer to potentially achieving justice.
- September 2024: Revlon missed a critical deadline for submitting evidence, prompting attorneys to file motions requesting the court to compel the company to turn over key documents.
- August 2024: Discovery proceedings continue, with both parties exchanging information regarding the potential link between cancer and hair relaxers.
- July 2024: A Georgia appeals court rejected L'Oréal's attempt to dismiss a lawsuit in which the plaintiff claims years of using their products led to the development of uterine fibroids. The case will now move forward.
- June 2024: Maura Grossman, an attorney and professor at the University of Waterloo, has been appointed Special Master to help streamline the litigation process in the hair relaxer cases.
- May 2024: Attorneys are now required to use a third-party system for filing documents to the court, a move Judge Rowland believes will reduce delays caused by the federal electronic filing system.
- March 2024: The number of active lawsuits in the hair relaxer MDL has increased, with 8,387 cases now pending in the U.S. District Court for the Northern District of Illinois.
- January 2024: The hair relaxer MDL now has 8,026 claims against manufacturers such as L'Oréal and Revlon.
- December 2023: Both sides in the litigation are gathering evidence during the discovery phase to support their claims.
- November 2023: Judge Rowland denied the motion to dismiss the hair relaxer MDL, allowing thousands of claims to proceed.
- October 2023: Nearly 6,000 individuals have filed claims against L'Oréal and other companies involved in the hair relaxer lawsuits.
- September 2023: A Master Complaint was filed, consolidating all claims and evidence linking health issues to the use of chemical hair relaxers.
- July 2023: Hair relaxer manufacturers filed a motion to dismiss the claims, arguing that there is no definitive link between their products and cancer.
- February 2023: Around 60 hair straightener lawsuits were consolidated into an MDL in the U.S. District Court for the Northern District of Illinois, Eastern Division, overseen by Judge Mary Rowland.
